SHINE Medical says it will produce 70% of global demand for medical isotope moly-99

SHINE Medical Technologies proposed production facility in the Netherlands. Rendering courtesy of SHINE Medical Technologies.

Last updated on June 9th, 2021 at 05:33 pmSHINE Medical Technologies says it will produce 70% of the global patient need for molybdenum-99, a diagnostic isotope used in nuclear medicine. The Janesville-based company is building a production facility for molybdenum-99 or moly-99 in Wisconsin, but SHINE now plans to construct a second facility in Europe,

Want to Read the Entire Article?

Become a BizTimes Insider today and get immediate access to our subscriber-only content and much more.

Become an Insider Now

Already an Insider? Log In

Or purchase a bypass link here

Sign up for BizTimes Daily Alerts

Stay up-to-date on the people, companies and issues that impact business in Milwaukee and Southeast Wisconsin

No posts to display